Skip to main content
. 2016 Nov 17;6:37332. doi: 10.1038/srep37332

Table 3. Comparison of macular and nerve choroidal thickness among chronic LHON patients, DOA patients and the control group.

  Chronic LHON patients DOA patients Control group Chronic LHON patients vs Control group DOA patients vs Control group Chronic LHON patients vs DOA patients
Average macular choroidal thickness (μm) 259.8 ± 67.9 250.9 ± 83.4 309.5 ± 38.2 p = 0.002** p < 0.0001** p = 1.0
Macular choroidal SF thickness (μm) 274.9 ± 77.3 254.4 ± 85.2 344.1 ± 49.1 p < 0.0001** p < 0.0001** p = 0.618
Macular choroidal 1500  N thickness (μm) 217.4 ± 73.0 212.9 ± 95.8 256.6 ± 59.2 p = 0.084 p = 0.032* p = 1.0
Macular choroidal 750  N thickness (μm) 252.4 ± 76.8 237.0 ± 85.9 309.2 ± 57.4 p = 0.030* p < 0.0001** p = 1.0
Macular choroidal 1500  S thickness (μm) 260.5 ± 71.3 268.9 ± 79.5 317.6 ± 42.9 p = 0.001** p = 0.003** p = 1.0
Macular choroidal 750  S thickness (μm) 262.8 ± 77.4 261.6 ± 80.81 318.2 ± 44.2 p = 0.002** p = 0.001** p = 1.0
Macular choroidal 1500  T thickness (μm) 257.3 ± 70.5 254.9 ± 80.6 300.1 ± 51.3 p = 0.020* p = 0.008* p = 1.0
Macular choroidal 750  T thickness (μm) 270.4 ± 73.4 257.1 ± 82.6 322.3 ± 44.3 p = 0.030* p < 0.0001** p = 1.0
Macular choroidal 1500  I thickness (μm) 274.3 ± 69.4 260.4 ± 80.5 303.9 ± 40.3 p = 0.143 p = 0.008** p = 1.0
Macular choroidal 750  I thickness (μm) 267.9 ± 68.2 255.8 ± 83.4 313.4 ± 43.7 p = 0.001** p = 0.015* p = 1.0
Average nerve choroidal thickness (μm) 157.4 ± 61.0 144.8 ± 61.0 167.9 ± 37.5 p = 1.0 p = 0.160 p = 0.874
Nerve choroidal T thickness (μm) 165.1 ± 70.0 147.6 ± 72.5 180.1 ± 37.9 p = 0.918 p = 0.070 p = 0.689
Nerve choroidal S thickness (μm) 172.8 ± 71.0 158.2 ± 66.5 182.3 ± 48.2 p = 1.0 p = 0.291 p = 0.940
Nerve choroidal N thickness (μm) 156.5 ± 69.9 150.7 ± 51.7 175.2 ± 51.3 p = 0.521 p = 0.177 p = 1.0
Nerve choroidal I thickness (μm) 135.2 ± 56.8 123.0 ± 52.9 133.3 ± 41.0 p = 1.0 p = 1.0 p = 0.900

LHON: Leber Hereditary Optic Neuropathy; DOA: Dominant Optic Atrophy; SF: sub-foveal; T: temporal quadrant; S: superior quadrant; N: nasal quadrant; I: inferior quadrant.

Data are showed as mean ± SD. Values were compared between each LHON group and healthy subjects, by means of one-way analysis of covariance (ANCOVA), followed by Bonferroni post hoc test. Gender was used as covariate in the analysis.

*<0.05, **<0.01.